WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

3.06.26

Firm Obtains Complete Jury Victory for Cyntec in Patent Validity Trial
On March 5, 2026, Wilson Sonsini Goodrich & Rosati secured a complete jury victory in a patent invalidity trial in the U.S. District Court for the Northern District of California on behalf of firm client Cyntec Company, Ltd. Rejecting defendant Chilisin’s arguments on obviousness, the jury found that all asserted claims of Cyntec’s U.S. Patent Nos. 8,922,312 and 9,481,037 were valid. Wilson Sonsini also represented Cyntec in a previous jury trial which had found that Chilisin willfully infringed both patents and imposed a 5 percent royalty. 
Client Highlights

2.04.25

Wilson Sonsini Secures Complete Jury Trial Victory for Via Transportation
On January 30, 2025, firm client and microtransit leader Via won a complete victory against its competitor, RideCo, following a seven-day jury trial and years of litigation in the U.S. District Court for the Western District of Texas.  After less than 3 hours of deliberation, the jury found that RideCo infringed three of Via’s patents on its virtual bus stop technology (U.S. Patent Nos. 9,562,785, 9,816,824, and 10,197,411) and ordered RideCo to pay damages, with total pretrial and ongoing damages to be determined. Via also prevailed against RideCo’s counterclaims, with the jury finding that Via did not infringe either of RideCo’s two asserted patents.
Client Highlights

12.17.24

Firm Secures Summary Judgment for Thermal Shipping Solutions in Patent Litigation
On December 15, 2024, a Wilson Sonsini patent litigation team secured a summary judgment victory for client Thermal Shipping Solutions based on recent Federal Circuit case law interpreting patent invalidity under the America Invents Act (AIA). This decision is one of the first in the nation to address the “public disclosure” and “derivation” exceptions under 35 U.S.C. § 102.
Client Highlights

11.04.24

Wilson Sonsini Secures Total Victory for Inhibrx Biosciences in Trade Secret Misappropriation Trial
On November 1, 2024, a federal jury in Delaware unanimously returned a verdict for Wilson Sonsini clients Inhibrx Biosciences and Dr. Brendan Eckelman. Inhibrx and its co-founder, Dr. Eckelman, are at the forefront of developing innovative therapies to combat cancer using the body’s own immune system. Their novel antibodies aim to both inhibit tumor growth and stimulate immune response.
Client Highlights

8.23.24

Wilson Sonsini Secures Complete Victory for Scale Computing in Patent Infringement Trial
On August 22, 2024, Wilson Sonsini Goodrich & Rosati secured a complete jury victory in a patent infringement trial in the U.S. District Court for the District of Delaware on behalf of firm client Scale Computing, Inc. Following a four-day trial, the jury unanimously found that Scale Computing’s accused products, including the Scale Computing Platform and its Scale Computing Reliable Independent Block Engine (SCRIBE), did not directly or indirectly infringe DataCore Software Corp.’s data storage patent (U.S. Patent No. 9,344,235). The jury also found all of DataCore’s asserted claims invalid as anticipated by the prior art.
Client Highlights

9.22.23

Wilson Sonsini Secures Victory for Epistar in Patent Damages Trial
On September 15, 2023, Wilson Sonsini Goodrich & Rosati secured a complete jury victory in a patent damages trial in the U.S. District Court for the Central District of California on behalf of firm client and plaintiff Epistar in Epistar Corp. v. Lowe’s Home Centers LLC, No.  17-cv-3219-JAK. Following a three-day jury trial, the jury returned a complete victory for Epistar, awarding the requested running royalty rate of 4 percent and full royalty base that Epistar sought. Earlier in this case, another jury found each and every patent-in-suit both valid and infringed, findings that the trial court has already upheld.
Client Highlights

5.09.22

Wilson Sonsini Obtains Permanent Injunction and Treble Damages for Cyntec in Patent Litigation Following Complete Jury Victory
On May 6, 2022, Wilson Sonsini prevailed on its request for a permanent injunction and treble damages on behalf of Taiwan-based semiconductor company Cyntec in its patent dispute with Chilisin Electronic Corp. in the U.S. District Court for the Northern District of California. 
Client Highlights

12.08.21

Wilson Sonsini Secures Jury Trial Victory for Epistar in Patent Litigation
On December 6, 2021, Wilson Sonsini secured a jury trial victory for Taiwan-based semiconductor company Epistar Corporation against Lowe’s Home Centers in the U.S. District Court for the Central District of California.
Client Highlights

9.02.21

Wilson Sonsini Secures Complete Jury Trial Victory for Cyntec in Patent Litigation
On September 1, 2021, Wilson Sonsini secured a complete trial victory for Taiwan-based semiconductor company Cyntec in the U.S. District Court for the Northern District of California when a jury unanimously found in favor of Cyntec in its patent dispute with Chilisin Electronic Corp.

Cyntec and Chilisin are two leading companies in the production of small, high-performance molding chokes (inductors). These chokes are critical to the operation of virtually all mobile devices, including smart phones, tablets, and laptops. The court found that Chilisin’s mixed-powder molded-type chokes used in smartphones, tablets, notebooks, and other compact-size electronics infringe two Cyntec patents, U.S. Patent Nos. 8,922,312 and U.S. Patent No. 9,481,037. The jury awarded Cyntec lost profits and also assessed a reasonable royalty at 5 percent. Importantly, the jury found that Chilisin’s infringement was willful, and that Chilisin has induced its customers to infringe through importation of accused products into the United States.

The Wilson Sonsini team that represented Cyntec in the litigation included partners James Yoon and Lucy Yen; associates Christopher Mays, Celine Liu; paralegal Bruce Chiang; and support staff Kathy Ramos and Robin Pezzimenti.
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.